Hepta Bio
San Francisco
About Hepta Bio
Hepta determines chronic disease early by using cfDNA epigenetic analysis and AI to provide accurate, non-invasive diagnostics at the community level.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.7M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: hepta.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hepta-bio-67812 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.